Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial
Authors
Keywords
-
Journal
Trials
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-29
DOI
10.1186/s13063-015-0772-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Risk Factors of Severe Acute Kidney Injury Induced by Cisplatin
- (2017) Tomohiro Mizuno et al. ONCOLOGY
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
- (2013) Junichi Matsubara et al. CIRCULATION JOURNAL
- Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
- (2013) P.-H. Groop et al. DIABETES CARE
- Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection
- (2013) D. Katagiri et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels
- (2013) Hugo You-Hsien Lin et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
- (2013) Kwon Wook Joo et al. BMC Nephrology
- Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus
- (2012) Harshal R. Patil et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update
- (2012) Neife Aparecida Guinaim dos Santos et al. ARCHIVES OF TOXICOLOGY
- Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Gemigliptin, a Dipeptidyl Peptidase-IV Inhibitor: A Crossover Drug–Drug Interaction Study in Healthy Male Korean Volunteers
- (2012) Yook-Hwan Noh et al. CLINICAL THERAPEUTICS
- KDIGO (Kidney Disease: Improving Global Outcomes) Criteria Could Be a Useful Outcome Predictor of Cisplatin-Induced Acute Kidney Injury
- (2012) Tomohiro Mizuno et al. ONCOLOGY
- In Vivo DPP-4 Inhibition to Enhance Engraftment of Single-Unit Cord Blood Transplants in Adults with Hematological Malignancies
- (2012) Sherif S. Farag et al. STEM CELLS AND DEVELOPMENT
- Vildagliptin Improves Endothelium-Dependent Vasodilatation in Type 2 Diabetes
- (2011) P. C. M. van Poppel et al. DIABETES CARE
- CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation
- (2011) W. Jungraithmayr et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)
- (2011) Cristina Mega et al. Experimental Diabetes Research
- Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
- (2010) M. Sauve et al. DIABETES
- Predicting Cisplatin-Induced Acute Kidney Injury by Urinary Neutrophil Gelatinase-Associated Lipocalin Excretion: A Pilot Prospective Case-Control Study
- (2010) Flavio Gaspari et al. NEPHRON CLINICAL PRACTICE
- Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
- (2009) Kyoung Soo Lim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary cultures
- (2009) Richard David Wainford et al. TOXICOLOGY IN VITRO
- Primary Graft Dysfunction in Lung Transplantation: The Role of CD26/Dipeptidylpeptidase IV and Vasoactive Intestinal Peptide
- (2009) Wei Zhai et al. TRANSPLANTATION
- A comparison of the rates of cisplatin (cDDP) - induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure
- (2009) Lily Leu et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Organic Cation Transporters and their Pharmacokinetic and Pharmacodynamic Consequences
- (2008) Min-Koo Choi et al. Drug Metabolism and Pharmacokinetics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started